Curcumin Encapsulated into Biocompatible Co-Polymer PLGA Nanoparticle Enhanced Anti-Gastric Cancer and Anti-Helicobacter Pylori Effect

Background: The current disadvantages (high cost, toxicity, resistance) of chemotherapy for gastric cancer opted people for alternative therapy from natural source. Curcumin (natural product) possess multiple biological activities but low bio-availability limits their uses as therapeutic. The Nano-formulation of curcumin increased the bioavailability and productivity of anti-cancer and anti-bacterial properties. The present study was initiated to determine the anti-cancer and anti-bacterial effect of Nano curcumin against gastric cancer and H. pylori. Methods: Curcumin loaded PLGA nanoparticles (CUR-NPs) was prepared by single emulsion solvent evaporation method. The MIC were determined using agar dilution method to find the anti-H. Pylori activity of Nano curcumin. The cytotoxicity of Nano curcumin was evaluated by MTT assay and the apoptotic effect (cell cycle arrest and morphology change) was shown by PI staining and microscopy. Results: The MIC of nanocurcumin and curcumin for all four H. pylori strains were 8 µg/ml and 16 µg/ml respectively. The inhibition rate of gastric cancer cells after treatment with curcumin was increased from 6% to 67% for 24h, from 8% to 75% for 48h, from 10% to 83% for 72h. In case of nanocurcumin, the inhibition rate increased from 7% to 69% for 24h, 11% to 87% for 48h and 16% to 97% for 72h. The IC50 of curcumin and Nano-curcumin were 24.20 µM and 18.78 µM respectively for 72 h. The population of cells in sub-G0 population increased from 4.1% in the control group to 24.5% and 57.8% when treated with curcumin and nanocurcumin respectively. After 72h of treatment with nanocurcumin, the apoptotic cells population increased as compared to native curcumin treated cells. Conclusion: The Nano curcumin might be used as a potential therapeutics against gastric cancer and H. Pylori. There is need of further in vivo study in order to validate CUR-NPs activity.     

Four-year clinical evaluation of Class II nano-hybrid resin composite restorations bonded with a one-step self-etch and a two-step etch-and-rinse adhesive

Objective

The objective of this prospective clinical trial was to evaluate the 4-year clinical performance of an ormocer-based nano-hybrid resin composite (Ceram X; Dentsply/DeTrey) in Class II restorations placed with a one-step self-etch (Xeno III; Dentsply/DeTrey) and two-step etch-and-rinse adhesive (Ivoclar Vivadent).

Methods

Seventy-eight participants received at random at least two, as similar as possible, Class II restorations of the nano-hybrid resin composite bonded with either a single step self-etch adhesive or a control 2-step etch-and-rinse adhesive. The 165 restorations were evaluated using slightly modified USPHS criteria at baseline and then yearly during 4 years.

Results

162 restorations were evaluated at 4 years. Postoperative sensitivity was observed in 6 patients (3 Xeno III, 3 Exite) between 1 and 3 weeks. Eleven failed restorations (6.8%) were observed during the follow up. Seven in the one-step self-etch adhesive group (7.7%) and four in the 2-step etch-and-rinse group (5.6%). This resulted in non-significant different annual failure rates of 1.9% and 1.4%, respectively. Fracture of restoration was the main reason for failure.

Conclusion

The ormocer-based nano-hybrid resin composite showed a good clinical performance in Class II cavities during the 4 year evaluation. No significant difference was seen in overall clinical effectiveness between the two adhesives.     

纳米磷酸三钙复合人工骨的Ames致突变试验

目的 从基因角度探讨纳米磷酸三钙／胶原复合人工骨的遗传毒理学特性。以了解此复合人工骨的生物相容性，为其在骨缺损修复领域的临床应用提供依据。方法 将纳米级磷酸三钙（β－TCP）同胶原复合，制成纳米β－TCP／胶原复合人工骨，并制备浸提液，采用Ames致突变试验，以生理盐水为阴性对照，测试其对鼠伤寒沙门菌的致突变比值（MR＝实验组回变菌落数Rt／阴性对照组回变菌落数Rc）。结果 阳性对照组各菌株回变菌落平均数均超过其相应阴性对照组回变菌落平均数的二倍以上（MRp＞2)，此复合人工骨的浸提液各剂量组对鼠伤寒沙门菌的致突变比值MR均小于2。结论 纳米磷酸三钙／胶原复合人工骨不会引起鼠伤寒沙门菌的回复突变数增加，提示此人工骨不会引起基因突变。     

新型抗感染创面修复材料：纳米银

银以金属银、硝酸银、磺胺嘧啶银等多种形式应用于烧伤及多种细菌感染的治疗。随着抗生素的发现与应用,这些银复合物的应用显著下降。近年来,纳米技术因可调节金属尺寸至纳米级,使金属的化学、物理与光学性质有了极大的改变．纳米级的金属银成为一种潜在的抗菌剂。由于抗生素耐药性的发生,纳米银的应用具有广阔前景。     

纳米银凝胶经阴道给药后在家兔体内的分布特征

目的 给予家兔阴道内纳米银凝胶后,研究银在家兔体内的分布情况.方法 单剂量和多剂量经♀家兔阴道给予纳米银凝胶200 mg∶ kg-1后,于不同时间点处死家兔并剖取主要组织器官,用ICP-MS法测定给药前、后家兔各器官中银的含量.结果 与0h组比较,单剂量给药后,阴道、子宫和肝脏中银的含量明显增加,其余组织中未见明显分布,给药72 h后各组织中银的含量均恢复至本底水平;多剂量给药后,末次给药2 ～24 h内阴道、子宫、肝脏、脾、肾、大肠和小肠中有银的分布,心、脑、肺和胃未见明显分布,末次给药72 h后各组织中银的含量均恢复至本底水平.结论 单剂量和多剂量经家兔阴道给予纳米银凝胶后,给药2 ～24 h内银在组织中有分布,给药72 h后各组织中均未见明显银蓄积.     

Effect of nano copper on visceral organs and the contents of trace elements in weanling pigs

We determine the effect of nano copper on visceral organs and contents of trace elements in organs and serum in weanling pigs. Our results showed that following supplementary concentration with 25, 50 and 200?mg/kg/day of nano copper, contents of copper shows trend of increasing in liver, kidney and intestinal; and ferrum shows gradually decreasing. The histopathological examination showed hemolysis, degeneration, nucleus pycnosis in liver, while renal tubular epithelial cell exfoliation and lymphocyte infiltration were found in kidney on supplementation of high concentration of nano-copper. Therefore, dietary supplementation of nano-copper 25?mg/kg b.wt could be a potential substitute for weaning piglets.     

纳米银抗菌敷料治疗78例烧伤患者的疗效及护理体会

目的观察纳米银抗菌辅料对烧伤患者创面的治疗效果。方法对天津市职业病防治院外科收治的78例不同程度烧伤患者,在入院经过清创处理消毒创面后,均选择使用纳米银抗菌敷料进行换药治疗,同时辅以抗感染、抗休克治疗,责任护士严密观察病情和伤口创面变化,同时进行精心的心理和饮食护理。结果78例患者创面均达到I期愈合,未发生并发症,未留有明显瘢痕。结论应用纳米银抗菌敷料治疗烧伤具有减轻疼痛、控制感染、促进愈合、方法简便等优势,临床治疗效果满意。     

脑靶向纳米载体材料研究进展

血脑屏障的存在使许多药物难以入脑,促进药物跨血脑屏障成为关键。纳米粒具有小粒子特征,能携载药物跨血脑屏障实现脑靶向,并提高脑内药物浓度。本文综述了PLA、PLGA、PCL、PBCA、PAMAM、CS等作为载体材料制备的纳米粒入脑的情况,并重点探讨纳米粒粒径大小、表面修饰等对入脑的影响。     

组织工程骨修复兔下颌骨缺损的实验研究

目的:探讨以兔骨髓基质细胞(BMSCs)为种子细胞、纳米羟基磷灰石/胶原(nHAC)为支架材料、兔自体富血小板血浆(PRP)为生长因子,构建组织工程骨修复兔下颌骨缺损能力。方法:兔下颌骨体部15mm×15mm全层骨缺损分别采取:A组,组织工程骨;B组,自体髂骨;C组,单纯nHAC材料;D组,对照组修复。术后1、3、6个月行放射性核素骨检测、骨密度测定及组织学观察。结果:放射性核素骨检测:术后1、3个月,A、B组成骨代谢能力明显优于C、D组,术后6个月时,各组之间骨代谢能力无明显差异;骨密度测定:A、B、C组骨缺损区域骨密度逐渐增加明显高于D组,术后3个月A组、B组骨密度较C组明显提高;组织学检查:A组术后1个月可见小片状类骨质出现,nHAC开始降解,术后3个月时新生骨成大片状结构,术后6个月nHAC几乎全部降解,缺损由骨组织修复,其成骨量与B组无明显差异却明显大于C组,D组仅为纤维组织修复。结论:本实验构建的组织工程骨修复颌骨缺损能力与自体髂骨相似而强于单独使用nHAC,且nHAC材料于体内可完全降解,因此BMSCs与nHAC及自体PRP复合所构建的组织工程骨是一种良好的骨缺损替代材料。     

两种纳米形貌对MG63成骨细胞增殖、分化的影响

目的:评价钛表面纳米管和纳米颗粒形貌对MG63成骨细胞的增殖、分化能力的影响。方法:通过磁控溅射和阳极氧化技术制备纳米颗粒和纳米管形貌。采用扫描电镜和轮廓仪表征材料表面形貌以及粗糙度,并将MG63成骨细胞株与不同形貌的钛材料进行复合培养,检测1d、4d、7d的MTT值及4d、7d的碱性磷酸酶活性。结果:培养1d、4d、7d后,纳米管和纳米颗粒组MTT值高于对照组,7d时,纳米管组MTT值高于纳米颗粒组;培养7d后,纳米形貌实验组碱性磷酸酶活性明显高于对照组。结论:纳米管和纳米颗粒形貌均有利于成骨细胞的增殖和分化。相对于纳米颗粒,表面的纳米管形貌更有利于促进成骨细胞的增殖。